These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17437162)
1. Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. Ogawa H; Kameda H; Nagasawa H; Sekiguchi N; Takei H; Tsuzaka K; Amano K; Takeuchi T Mod Rheumatol; 2007; 17(2):92-7. PubMed ID: 17437162 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice. Ogawa H; Kameda H; Amano K; Takeuchi T Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. Fu LW; Yang LY; Chen WP; Lin CY Br J Rheumatol; 1998 Feb; 37(2):217-21. PubMed ID: 9569080 [TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of lupus nephritis with cyclosporin A. Tam LS; Li EK; Leung CB; Wong KC; Lai FM; Wang A; Szeto CC; Lui SF QJM; 1998 Aug; 91(8):573-80. PubMed ID: 9893761 [TBL] [Abstract][Full Text] [Related]
6. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis. Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077 [TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F Lupus; 2006; 15(8):490-5. PubMed ID: 16942000 [TBL] [Abstract][Full Text] [Related]
8. [Cyclosporin therapy of patients with systemic lupus erythematosus]. Gergely P Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258 [TBL] [Abstract][Full Text] [Related]
9. Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients. Matsumura R; Umemiya K; Sugiyama T; Sueishi M; Umibe T; Ichikawa K; Yoshimura M; Clin Exp Rheumatol; 2009; 27(3):416-21. PubMed ID: 19604433 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A in treatment of membranous lupus nephropathy. Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467 [TBL] [Abstract][Full Text] [Related]
11. Low-dose cyclosporine for active lupus nephritis: a dose titration approach. Sumethkul K; Kitumnuaypong T; Angthararak S; Pichaiwong W Clin Rheumatol; 2019 Aug; 38(8):2151-2159. PubMed ID: 30937637 [TBL] [Abstract][Full Text] [Related]
12. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis. Tang Z; Zhang J; Zhang S; Li L Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325 [TBL] [Abstract][Full Text] [Related]
13. Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis. Sawamura M; Sawa N; Ikuma D; Oba Y; Yamanouchi M; Sekine A; Mizuno H; Hasegawa E; Suwabe T; Hoshino J; Kono K; Kinowaki K; Ohashi K; Ubara Y Intern Med; 2023 Apr; 62(7):1037-1041. PubMed ID: 36070938 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Aringer M; Graninger WB; Steiner G; Smolen JS Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus. Yang TH; Wu TH; Chang YL; Liao HT; Hsu CC; Tsai CY; Chou YC Clin Nephrol; 2018 Apr; 89(4):277-285. PubMed ID: 29319493 [TBL] [Abstract][Full Text] [Related]
16. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study. Dostál C; Tesar V; Rychlík I; Zabka J; Vencovský J; Bartûnková J; Stejskalová A; Tegzova D Lupus; 1998; 7(1):29-36. PubMed ID: 9493146 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Hussein MM; Mooij JM; Roujouleh H Clin Nephrol; 1993 Sep; 40(3):160-3. PubMed ID: 8403571 [TBL] [Abstract][Full Text] [Related]
18. Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Hallegua D; Wallace DJ; Metzger AL; Rinaldi RZ; Klinenberg JR Lupus; 2000; 9(4):241-51. PubMed ID: 10866094 [TBL] [Abstract][Full Text] [Related]
19. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043 [TBL] [Abstract][Full Text] [Related]
20. Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up. Li J; Zhang YM; Qu Z; Zhao MH; Liu G Am J Med Sci; 2010 Jun; 339(6):532-6. PubMed ID: 20442650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]